220 related articles for article (PubMed ID: 33358334)
1. Association between circadian rhythm disruption and polycystic ovary syndrome.
Wang F; Xie N; Wu Y; Zhang Q; Zhu Y; Dai M; Zhou J; Pan J; Tang M; Cheng Q; Shi B; Guo Q; Li X; Xie L; Wang B; Yang D; Weng Q; Guo L; Ye J; Pan M; Zhang S; Zhou H; Zhen C; Liu P; Ning K; Brackenridge L; Hardiman PJ; Qu F
Fertil Steril; 2021 Mar; 115(3):771-781. PubMed ID: 33358334
[TBL] [Abstract][Full Text] [Related]
2. Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis.
Johnson BS; Krishna MB; Padmanabhan RA; Pillai SM; Jayakrishnan K; Laloraya M
Hum Reprod; 2022 Jul; 37(8):1835-1855. PubMed ID: 35728080
[TBL] [Abstract][Full Text] [Related]
3. Morning Circadian Misalignment Is Associated With Insulin Resistance in Girls With Obesity and Polycystic Ovarian Syndrome.
Simon SL; McWhirter L; Diniz Behn C; Bubar KM; Kaar JL; Pyle L; Rahat H; Garcia-Reyes Y; Carreau AM; Wright KP; Nadeau KJ; Cree-Green M
J Clin Endocrinol Metab; 2019 Aug; 104(8):3525-3534. PubMed ID: 30888398
[TBL] [Abstract][Full Text] [Related]
4. Shift Work Disrupts Circadian Regulation of the Transcriptome in Hospital Nurses.
Resuehr D; Wu G; Johnson RL; Young ME; Hogenesch JB; Gamble KL
J Biol Rhythms; 2019 Apr; 34(2):167-177. PubMed ID: 30712475
[TBL] [Abstract][Full Text] [Related]
5. Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary syndrome.
Kim JW; Kang KM; Yoon TK; Shim SH; Lee WS
Fertil Steril; 2014 Aug; 102(2):548-554.e2. PubMed ID: 24875397
[TBL] [Abstract][Full Text] [Related]
6. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
7. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
8. Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome.
Li S; Zhai J; Chu W; Geng X; Chen ZJ; Du Y
Transl Res; 2020 May; 219():13-29. PubMed ID: 32119846
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-9119 regulates cell viability of granulosa cells in polycystic ovarian syndrome via mediating Dicer expression.
Ding Y; He P; Li Z
Mol Cell Biochem; 2020 Feb; 465(1-2):187-197. PubMed ID: 31894528
[TBL] [Abstract][Full Text] [Related]
10. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells.
Qu F; Wang FF; Yin R; Ding GL; El-Prince M; Gao Q; Shi BW; Pan HH; Huang YT; Jin M; Leung PC; Sheng JZ; Huang HF
J Mol Med (Berl); 2012 Aug; 90(8):911-23. PubMed ID: 22349439
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern of circadian genes and steroidogenesis-related genes after testosterone stimulation in the human ovary.
Chen M; Xu Y; Miao B; Zhao H; Luo L; Shi H; Zhou C
J Ovarian Res; 2016 Sep; 9(1):56. PubMed ID: 27614897
[TBL] [Abstract][Full Text] [Related]
12. Activation of TGF-β1/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cells.
Shen H; Wang Y
J Cell Physiol; 2019 Jul; 234(7):11976-11985. PubMed ID: 30536903
[TBL] [Abstract][Full Text] [Related]
13. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome.
Ding L; Gao F; Zhang M; Yan W; Tang R; Zhang C; Chen ZJ
Fertil Steril; 2016 May; 105(5):1330-1337.e3. PubMed ID: 26868993
[TBL] [Abstract][Full Text] [Related]
14. Altered m
Zhang S; Deng W; Liu Q; Wang P; Yang W; Ni W
J Cell Mol Med; 2020 Oct; 24(20):11874-11882. PubMed ID: 32869942
[TBL] [Abstract][Full Text] [Related]
15. Serum melatonin in women with polycystic ovary syndrome.
Terzieva DD; Orbetzova MM; Mitkov MD; Mateva NG
Folia Med (Plovdiv); 2013; 55(2):10-5. PubMed ID: 24191394
[TBL] [Abstract][Full Text] [Related]
16. Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin.
Liu XY; Yang YJ; Tang CL; Wang K; Chen JJ; Teng XM; Ruan YC; Yang JZ
Fertil Steril; 2019 Jan; 111(1):157-167. PubMed ID: 30477916
[TBL] [Abstract][Full Text] [Related]
17. Abnormality of Klotho Signaling Is Involved in Polycystic Ovary Syndrome.
Mao Z; Fan L; Yu Q; Luo S; Wu X; Tang J; Kang G; Tang L
Reprod Sci; 2018 Mar; 25(3):372-383. PubMed ID: 28673204
[TBL] [Abstract][Full Text] [Related]
18. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome.
Zhang C; Ma J; Wang W; Sun Y; Sun K
Hum Reprod; 2018 Nov; 33(11):2096-2106. PubMed ID: 30272163
[TBL] [Abstract][Full Text] [Related]
20. Neurotransmitter alteration in a testosterone propionate-induced polycystic ovarian syndrome rat model.
Chaudhari NK; Nampoothiri LP
Horm Mol Biol Clin Investig; 2017 Feb; 29(2):71-77. PubMed ID: 27802175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
